Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_3
3
30%
Ph phase_1
3
30%
Ph phase_2
4
40%

Phase Distribution

3

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(8)
Terminated(2)

Detailed Status

Completed8
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (30.0%)
Phase 24 (40.0%)
Phase 33 (30.0%)

Trials by Status

terminated220%
completed880%

Recent Activity

0 active trials
Showing 5 of 10
terminatedphase_2

A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease

NCT02628769
completedphase_1

Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin

NCT02348424
terminatedphase_2

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

NCT02605122
completedphase_3

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

NCT02210325
completedphase_1

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

NCT02268279
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT02628769Phase 2

A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease

Terminated
NCT02348424Phase 1

Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin

Completed
NCT02605122Phase 2

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

Terminated
NCT02210325Phase 3

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

Completed
NCT02268279Phase 1

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Completed
NCT02510599Phase 2

Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis

Completed
NCT01968733Phase 3

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Completed
NCT01591447Phase 2

Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea

Completed
NCT01756339Phase 3

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Completed
NCT01966055Phase 1

Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10